Ronni R Plovsing Selected Research

Ronni R Plovsing Research Topics

Disease

9	COVID-19 01/2024 - 01/2021
8	Sepsis (Septicemia) 11/2022 - 12/2012
6	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2024 - 05/2015
6	Inflammation (Inflammations) 01/2017 - 07/2014
5	Critical Illness (Critically Ill) 12/2022 - 09/2014
3	Septic Shock (Toxic Shock Syndrome) 01/2022 - 09/2014
3	Endotoxemia 01/2017 - 01/2013
2	Hypoxia (Hypoxemia) 01/2022 - 10/2013
2	Pneumonia (Pneumonitis) 01/2017 - 05/2015
1	Thrombosis (Thrombus) 01/2023
1	Neoplasms (Cancer) 01/2023
1	Hemorrhage 01/2023
1	Traumatic Brain Injuries (Traumatic Brain Injury) 11/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Acidosis 01/2021
1	Infections 01/2021
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2021
1	COVID-19 related adult multisystem inflammatory disease 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2017
1	Acute-Phase Reaction 05/2016
1	Anticholinergic Syndrome 01/2016
1	Tachycardia (Tachyarrhythmias) 01/2016
1	Anuria 01/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Apnea 01/2016
1	Hyperoxia 10/2013

Drug/Important Bio-Agent (IBA)

7	LipopolysaccharidesIBA 11/2016 - 12/2012
4	CytokinesIBA 01/2024 - 01/2017
3	InterferonsIBA 01/2024 - 01/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2024 - 12/2022
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 10/2013
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2015 - 09/2014
2	Hemostatics (Antihemorrhagics)IBA 10/2013 - 01/2013
2	ProcalcitoninIBA 10/2013 - 01/2013
1	AutoantibodiesIBA 01/2024
1	Interferon Type IIBA 01/2024
1	GasesIBA 01/2023
1	fibrin fragment D (D-dimer)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 12/2022
1	1,2-Dipalmitoylphosphatidylcholine (Dipalmitoylphosphatidylcholine)IBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 01/2022
1	Surface-Active Agents (Surfactants)IBA 01/2022
1	AntibodiesIBA 01/2021
1	Cell Adhesion MoleculesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	EndotoxinsIBA 01/2017
1	EnzymesIBA 01/2017
1	Interleukin-2 (IL2)IBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2017
1	Interleukin-17 (Interleukin 17)IBA 01/2017
1	LectinsIBA 05/2016
1	Proteins (Proteins, Gene)FDA Link 05/2016
1	Blood Proteins (Serum Proteins)IBA 05/2016
1	Scopolamine (Hyoscine)FDA Link 01/2016
1	Atropine FDA LinkGeneric 01/2016
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2016
1	Neuroprotective AgentsIBA 07/2015
1	Oxygen (Dioxygen)IBA 10/2013
1	C-Reactive ProteinIBA 10/2013
1	CatecholaminesIBA 10/2013
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2013
1	Protein CIBA 10/2013
1	Fibrinogen (Factor I)FDA Link 01/2013

Therapy/Procedure

1	Artificial Respiration (Mechanical Ventilation) 01/2023
1	Neurological Rehabilitation 11/2022
1	Anesthesia 01/2016